Aemetis vs Gevo
Aemetis (AMTX) and Gevo (GEVO) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $59.2M
- Last close
- $0.8092
- 12 months
- −47.5%
- Market value
- $398M
- Last close
- $1.61
- 12 months
- −13.9%
At a glance
- The biggest part of Aemetis's revenue is California Ethanol (78%); at Gevo it is GevoND (85%).
- By market value, Gevo ($398M) is about 6.7 times Aemetis ($59M).
- Over the last 12 months Aemetis's share price moved −47.5% and Gevo's −13.9%; against the S&P 500 that is −53.2 points and −19.6 points.
- In their last fiscal years Aemetis kept -39.0% of revenue as net income and Gevo -21.1%.
- In the last 90 days insiders reported 0 open-market purchases at Aemetis and 2 at Gevo; members of Congress disclosed 0 trades in Aemetis and 0 in Gevo.
- Next results: Aemetis Mar 10, 2027, Gevo Mar 3, 2027.
How each one makes money: Aemetis revenue · Gevo revenue
Share prices on one chart
Aemetis and Gevo, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Aemetis AMTXNASDAQ · Industrial Organic Chemicals | Gevo GEVONASDAQ · Industrial Organic Chemicals | |
|---|---|---|
| Size and profitability | ||
| Market value | $59.2M | $398M |
| Revenue, last fiscal year | $198M | $161M |
| Net income, last fiscal year | −$77M | −$33.8M |
| Net marginNet income as a share of revenue | -39.0% | -21.1% |
| Free cash flow | −$22.7M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Aemetis different from Gevo?
Aemetis (AMTX) is in Industrial Organic Chemicals on NASDAQ, with $198M of revenue in its last fiscal year and a net margin of -39.0%. Gevo (GEVO) is in Industrial Organic Chemicals on NASDAQ, with $161M of revenue in its last fiscal year and a net margin of -21.1%. The biggest part of Aemetis's revenue is California Ethanol (78%); at Gevo it is GevoND (85%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Aemetis and Gevo compare in size?
Gevo has the larger market value: Aemetis $59.2M and Gevo $398M, at the last close.
Whose share price rose more over the last 12 months, AMTX or GEVO?
Over the last 12 months Aemetis moved −47.5% and Gevo −13.9%. Past price moves say nothing about the future.
Which has had more insider buying, Aemetis or Gevo?
Since 2006, Gevo insiders reported 38 open-market purchases against 6 for Aemetis. These are counts of what was filed, not a view on either stock.
Do members of Congress trade AMTX or GEVO?
In the last 12 months, members of Congress disclosed 0 trades in Aemetis (AMTX) and 0 in Gevo (GEVO).
When did insiders last buy AMTX and GEVO?
Aemetis: Dec 20, 2021. Gevo: Aug 24, 2026.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Aemetis pageGevo pageRare insider trades this weekAll comparisons
https://oqro.io/compare/amtx-vs-gevo

